3. Epidemiologi

Larsen, I. K. (2019). Cancer in Norway 2018: cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway.

Larsen, I. K. (2021). Cancer in Norway 2020: cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway.

Nasjonalt kvalitetsregister for melanom (2021). Årsrapport 2020: resultater og forbedringstiltak fra Nasjonalt kvalitetsregister for melanom Oslo: Kreftregisteret. Hentet fra https://www.kvalitetsregistre.no/sites/default/files/2021-10/%C3%85rsrapport%20Nasjonalt%20kvalitetsregister%20for%20melanom%202020.pdf

Robsahm, T. E., Helsing, P., Nilssen, Y., Vos, L., Rizvi, S. M. H., Akslen, L. A., & Veierod, M. B. (2018). High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry. Clinical Epidemiology, 10, 537-548.

Robsahm, T. E., Helsing, P., Svendsen, H. L., & Veierød, M. B. (2021). Clinical Suspicion Sensitivity of Nodular and Superficial Spreading Melanoma. Acta dermato-venereologica, 101(4), adv00427.

Robsahm, T. E., Karagas, M. R., Rees, J. R., & Syse, A. (2014). New malignancies after squamous cell carcinoma and melanomas: a population-based study from Norway. BMC cancer, 14, 210.

Sacchetto, L., Zanetti, R., Comber, H., Bouchardy, C., Brewster, D. H., Broganelli, P., Chirlaque, M. D., Coza, D., ... Rosso, S. (2018). Trends in incidence of thick, thin and in situ melanoma in Europe. European journal of cancer, 92, 108-118.

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians, 71(3), 209-249.